Snap a photo, count carbs: app aims to simplify type 1 diabetes meals
NCT ID NCT05671679
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a smartphone app called SNAQ that estimates the carbohydrate content of a meal from a single photo. The goal was to see if using the app helps people with type 1 diabetes keep their blood sugar in a healthy range. 44 adults who already use an automated insulin pump system took part. The app is designed to make carb counting easier and more accurate.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- SNAQ smartphone food analysis app
- What this could lead to
- If it works, this app could make carb counting easier and help people with type 1 diabetes keep their blood sugar in a healthier range.
- What could go wrong
- This was a small, completed study with only 44 participants. The app may not improve blood sugar control for everyone, and relying on it could lead to estimation errors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
44 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Written informed consent * Adults (aged 18 years or older) * Type 1 diabetes (as defined by World Health Organization (WHO) for at least 12 month) * Current use of a commercial hybrid closed-loop system * HbA1c≤12% (measured within the past 3 months) * Willing to use the SNAQ app on a daily basis for over 3 weeks * The participant is willing to follow study specific instructions and share their treatment data with the study team Exclusion Criteria: * Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results * Previous use of SNAQ app for more than 5 days within the past 3 months * Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding * Severe visual impairment * Severe hearing impairment * Lack of reliable telephone facility for contact * Concomitant participation in another trial that interferes with the normal conduct of the study and interpretation of the study results * Participant not proficient in German
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 1 diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital
Bern, Canton of Bern, 3010, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can skin sensors replace finger pricks for diabetes care in kenya?
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Can a math model tune insulin pumps better than standard care?
- Can a group program stop eating disorders in type 1 diabetes?
- Can a Two-Punch immune therapy save insulin cells in newly diagnosed diabetes?
- Can a smart insulin pump tailored for pregnancy protect mothers and babies?